Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Liver Neoplasms × regorafenib × Clear all

Phase

Status

Completed 3 Terminated 2 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14 Carcinoma, Hepatocellular 8 Neoplasm Metastasis 3 Melanoma 2 Cholangiocarcinoma 2 Advanced Colorectal Cancer 2 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Tertiary Lymphoid Structures 1 TAS 102 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Mesothelioma, Malignant 1 Liver Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fatigue 1 Colorectal Cancer Metastatic 1 Colorectal Cancer Liver Metastases 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Biliary Tract Neoplasms 1 Asian Colorectal Cancer Patients 1 Advanced Colorectal Carcinoma 1 Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy 1 Adenocarcinoma 1

Interventions

Sorafenib 9 Radiofrequency Ablation 7 Oxaliplatin 7 Fluorouracil 6 Doxorubicin 6 Neoadjuvant Therapy 5 toripalimab 4 lenvatinib 4 Injections 4 Chemotherapy, Adjuvant 4 pembrolizumab 3 Ultrasonography 3 Thalidomide 3 Leucovorin 3 Irinotecan 3 Cisplatin 3 Bevacizumab 3 tislelizumab 2 sintilimab 2 durvalumab 2 camrelizumab 2 anlotinib 2 Walking Speed 2 Standard of Care 2 Radiosurgery 2 Oncolytic Virotherapy 2 Metformin 2 Liver Transplantation 2 Immunohistochemistry 2 High-Energy Shock Waves 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05134532 2023-04-26

HCC

CHA University

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡